Research programme: matrix metalloprotease inhibitors - Queens University of Belfast
Alternative Names: Matrix metalloprotease inhibitors research programme - Queen's University of BelfastLatest Information Update: 02 Apr 2003
Price :
$50 *
At a glance
- Originator Queens University Belfast
- Class
- Mechanism of Action Collagenase inhibitors; Metalloprotease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 02 Apr 2003 No development reported - Preclinical for Cancer in Northern Ireland (unspecified route)
- 03 Jul 2001 New profile
- 03 Jul 2001 Preclinical development for Cancer in Northern Ireland (Unknown route)